All Articles

In recently released study results of the phase 2 CodeBreaK 100 trial, sotorasib demonstrated a response rate across all trial subgroups.
Read More

Lung cancer incidence rates have declined due to a decrease in risk factors and improved screening and treatment.
Read More

Immune checkpoint inhibitors cause rare severe adverse events in patients, but most patients improve with treatment.
Read More

Patients with NSCLC harboring KRAS G12C have distinct imaging patterns from patients with other NSCLC genetic mutations.
Read More

On behalf of everyone at the Academy of Oncology Nurse & Patient Navigators (AONN+), it is my pleasure to announce that Tamika Felder will deliver the Keynote Address at the AONN+ 12th Annual Navigation & Survivorship Conference!
Read More


Earlier this year, oncology navigators from across the country attended the AONN+ Virtual Midyear Conference. This monograph will review the proceedings from 4 key sessions at the conference covering topics of smoking cessation, making a business case for financial navigation, screening in the covid era, and geriatric oncology.
Read More

Recent advances in the treatment of mCRPC include immunotherapies, such as sipuleucel-T, the first therapeutic cancer vaccine to receive approval from the US Food and Drug Administration.
Read More

Are you using these strategies to efficiently resolve conflicts in your professional life?
Read More

Clara Lambert, a Director of Financial Navigation, explains the complicated world of insurance.
Read More

Page 100 of 283

Journal of Oncology Navigation & Survivorship
JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country